Quality of Life (QOL) in Ragweed Allergic Patients Treated with Captisol-Enabled ® Budesonide Nasal Solution (32μg/spray) when Exposed to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Using an EEC-Specific Rhinoconjunctivitis Quality of Life Questionnaire (EEC-RQOLQ)

Quality of Life (QOL) in Ragweed Allergic Patients Treated with Captisol-Enabled ® Budesonide Nasal Solution (32μg/spray) when Exposed to Ragweed Pollen in an Environmental Exposure Chamber (EEC) Using an EEC-Specific Rhinoconjunctivitis Quality of Life Questionnaire (EEC-RQOLQ)

Methods A randomized, double-blind, placebo-controlled, single-center, cross-over study including 63 patients allergic to ragweed pollen was conducted.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2008-02, Vol.121 (2), p.S55-S55
Hauptverfasser: Salapatek, A, McCue, S, Patel, D, Patel, P, Pipkin, J.D, Zimmerer, R.O
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Pollen
Quality of life
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods A randomized, double-blind, placebo-controlled, single-center, cross-over study including 63 patients allergic to ragweed pollen was conducted.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2007.12.222